Machine Learning-Based Predictive Analytics for Early Cervical Cancer Diagnosis: A Comprehensive Review

Abstract

Cervical cancer ranks as a top cause of death for women around the world, especially in poorer countries where regular screening and prompt diagnosis are not easily available. In this regard, the early detection of the disease is very important, as the patient can easily recover. However, the traditional diagnostic methods, such as Pap smears and colposcopy, are difficult to manage because they absorb a lot of time and money and are not very accurate since they rely on the judgment of the expert. In this paper, we present a predictive system using machine learning for the early detection of cervical cancer based on patient demographics, medical history, and laboratory tests. The platform integrates data preprocessing, feature extraction, and selection techniques to deal with missing values, noise, and class imbalance. The multiple supervised learning algorithms that we have created include Logistic Regression, Decision Tree, K-Nearest Neighbors, Support Vector Machine, Random Forest, Gradient Boosting, AdaBoost, and XGBoost, and they have all been evaluated based on accuracy, precision, recall, and F1-score metrics. The implementation of the platform is done in Python and it provides an easy decision support interface for healthcare professionals. The system intends to accomplish early intervention by automating the prediction process and enhancing diagnostic accuracy, thus reducing clinical workload and contributing to the alleviation of the global cervical cancer burden, especially in healthcare settings that have limited resources.

Introduction

The document reviews the growing role of machine learning (ML) and deep learning (DL) in improving cervical cancer detection, which remains a major global health issue, especially in low-resource regions where late diagnosis is common. Traditional screening methods such as Pap smears, HPV testing, and biopsies are effective but limited by cost, subjectivity, labor intensity, and lack of accessibility. These limitations often lead to inconsistent results and delayed detection.

AI-based approaches, particularly CNNs and other deep learning models, have shown strong performance in analyzing medical images like Pap smears, colposcopy, and histopathology slides, often achieving accuracy comparable to experts. ML methods are also effective for structured clinical data, using algorithms such as SVM, Random Forest, and Logistic Regression. Ensemble and hybrid approaches further improve sensitivity and reduce false negatives. Multimodal systems combining imaging, clinical, genomic, and biomarker data are emerging as the most promising direction for personalized and accurate prediction, though they face challenges like data inconsistency and high computational cost.

Despite progress, key gaps remain: limited small or single-center datasets, poor generalization, lack of external validation, class imbalance, weak interpretability (“black-box” models), and difficulties in real-world clinical deployment, especially in low-resource settings. The literature emphasizes the need for standardized datasets, explainable AI, multimodal integration, and scalable, cost-effective systems.

The study adopts a systematic review methodology, analyzing preprocessing techniques, ML/DL models, imbalance handling (e.g., SMOTE), feature selection, and performance evaluation using metrics like accuracy, precision, recall, and F1-score. Comparative analysis shows that DL excels in imaging tasks while ML performs well on structured data, but real clinical adoption is still limited.

Conclusion

The paper presented a review that has analyzed and discussed in detail the recent advances in the application of machine learning and deep learning for cervical cancer detection and screening. The result of the analysis illustrated that the AI models, in particular, the deep learning approaches such as convolutional neural networks and ensemble learning methods, are almost flawless and can greatly minimize human mistakes and the workload of clinicians. Conversely, using classical machine learning techniques on organized clinical and demographic data has some benefits compared to AI, such as less computational power needed and easier understanding of the results. The literature on this topic indicates very clearly the great influence that data preprocessing, feature selection, and handling of class imbalance have on achieving reliable performance. However, the promising results were still linked with hurdles like the limited variation of datasets, the absence of standard evaluation protocols, insufficient external validation, and concerns about interpretability that keep on hindering the deployment of these methods in real-world situations. Moreover, the paper asserted that AI systems perform better if used as support in decision-making rather than as solutions in diagnostics. The pathway of future research should include the integration of different types of data, the creation of explainable AI, and the conducting of large-scale clinical validation to produce cervical cancer screening systems that are not only scalable and reliable but also suitable for the clinic.

References

[1] P. Xue, Y. Zhang, L. Wang, J. Chen, X. Li, and H. Zhou, “Deep learning enabled liquid-based cytology model for cervical cancer screening,” Nature Communications, vol. 16, no. 1, pp. 1–13, 2025. [2] P. Jiang, L. Zhang, Y. Zhao, and K. Wang, “A systematic review of deep learning-based cervical cytology screening,” Artificial Intelligence Review, Springer, vol. 56, no. 2, pp. 1021–1050, 2023. [3] B. Vázquez, A. Martínez, J. López, and R. Hernández, “Machine and deep learning for the diagnosis, prognosis, and treatment of cervical cancer: A scoping review,” Diagnostics, vol. 15, no. 3, pp. 1–22, 2025. [4] L. Liu, Y. Chen, Z. Wang, M. Sun, and H. Li, “Performance of artificial intelligence for diagnosing cervical intraepithelial neoplasia: A systematic review and meta-analysis,” eClinicalMedicine, vol. 68, pp. 102320, 2025. [5] T. Takahashi, K. Sato, M. Nakamura, and Y. Fujita, “Diagnostic accuracy for cervical intraepithelial neoplasia using AI-based colposcopic systems: A systematic review,” Journal of Medical Systems, vol. 49, no. 1, pp. 1–15, 2025. [6] M. Fang, Q. Liu, J. Huang, and Y. Zhou, “A systematic review on deep learning methods for cervical cytology image analysis,” Computer Methods and Programs in Biomedicine, vol. 244, pp. 107908, 2024. [7] S. K. Khare, R. Gupta, and P. Verma, “Artificial intelligence in cervical cytology and screening: A systematic review and research recommendations,” WIREs Data Mining and Knowledge Discovery, vol. 14, no. 1, e1503, 2024. [8] H. Mbelwa, A. Mtei, and J. M. Kihonda, “Computer vision-based methods for cervical cancer screening: A systematic review,” Computers in Biology and Medicine, vol. 174, pp. 108089, 2025. [9] M. A. Valles-Coral, J. R. González, and L. M. Torres, “Application of artificial intelligence in cervical cytology: A review,” Frontiers in Big Data, vol. 8, pp. 1182034, 2025. [10] A. Mosquera-Zamudio, C. Pérez-Ramírez, and D. Rodríguez, “Deep-learning approaches for cervical cytology nuclei segmentation: A review,” Diagnostics, vol. 15, no. 5, pp. 1–20, 2025. [11] P. Patre, S. Kulkarni, and R. Deshpande, “A deep dive into deep learning methods for cervical cancer detection,” Asian Pacific Journal of Cancer Prevention, vol. 26, no. 2, pp. 415–426, 2025. [12] S. S. Abrar, M. Hasan, and T. Ahmed, “Recent advances in machine learning applications for cervical cancer detection and prognosis,” Healthcare, vol. 13, no. 4, pp. 1–18, 2025. [13] A. Ramos-Casallas, L. Pardo, J. Silva, and M. Ortega, “Performance evaluation of machine learning models using sociodemographic and clinical data for cervical cancer detection,” European Journal of Cancer, vol. 189, pp. 35–46, 2025. [14] S. Mehammed, “Machine learning approaches in cervical cancer prediction: A systematic review,” Preprints, pp. 2025010345, 2025. [15] D. Giansanti, A. Morelli, and S. Maccioni, “Artificial intelligence in cervical cancer cytology diagnostics: A narrative review,” Bioengineering, vol. 12, no. 1, pp. 1–19, 2025.

Copyright

Copyright © 2026 Ms. Reshmi Pranabkumar Das , Prof. Tarun Yengatiwar. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.